Cosopt-S Multidose
Cosopt-S Multidose is a medicine authorised by Swissmedic under authorisation number 67198. The authorisation holder is Santen SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 July 2019 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 67198 |
|---|---|
| Name | Cosopt-S Multidose |
| Full name | Cosopt-S Multidose, collyre en solution |
| Authorisation holder | Santen SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | not stated |
| First authorisation | 16 July 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Cosopt-S Multidose, collyre en solution | B | 16 July 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Cosopt-S Multidose authorised in Switzerland?
Yes. Cosopt-S Multidose is authorised by Swissmedic under authorisation number 67198, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Cosopt-S Multidose have?
Cosopt-S Multidose is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Cosopt-S Multidose?
The authorisation holder is Santen SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.